Vivos Therapeutics, Inc.
VVOS
Revenue
4.05M
▲635.00k▲18.57%
3 Months ChangeAssets
15.84M
▲4.04M▲34.21%
3 Months ChangeLiabilities
9.50M
▼-1.73M▼-15.39%
3 Months ChangeFree Cash Flow
-2.67M
▲1.11M▲29.41%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001493152-24-037254
2024-09-18
Form 8-K
ID: 0001493152-24-036942
2024-09-17
Form 8-K
ID: 0001493152-24-036852
2024-09-12
Form 8-K
ID: 0001493152-24-036065
2024-08-15
Form 8-K
ID: 0001493152-24-032453
2024-08-14
Form 10-Q
ID: 0001493152-24-032240
2024-07-10
Form 8-K
ID: 0001493152-24-026723
2024-06-25
Form 8-K
ID: 0001493152-24-025102
2024-06-14
Form 8-K
ID: 0001493152-24-023871
2024-05-17
Form 8-K
ID: 0001493152-24-020446